MENU
GERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Geron (GERN) Ownership - Who owns Geron?
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.12B
P/E Ratio
N/A
Total Cash
339.77M
Projected Growth
N/A
Total Debt
87.26M
Revenue
29.48M
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
Fundamentals
GERN
Capitalization
1.12B
P/E Ratio
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash
340M
Total Cash/Share
0.53
Total Debt
87.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
29.5M
ROE
N/A
Book Value
292M
P/B Ratio
4.00
Cash Flow
N/A
Earnings
-0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
603K
Current Ratio
2.89
Current Revenue Per Employee
200503.55
Dividends Per Share - Security
N/A
EBITDA
-187.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.39
Revenue To Assets
-46.90
Shares Held By Institutions
2.91B
Shares Outstanding - Current
637M
Total Liabilities
153M
Total Volume MTD
N/A
Value
-1
Gain YTD
-50.282
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic products for cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com